Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 131–131 | Cite as

Darunavir/lamivudine/ritonavir

Diarrhoea and rash: 2 case reports
Case report
  • 27 Downloads

Reference

  1. Fontecha M, et al. Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir. Infectious Diseases 51: 293-298, No. 4, 2019. Available from: URL: http://doi.org/10.1080/23744235.2018.1554908 -Spain

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations